Us Bancorp \De\ Cytek Biosciences, Inc. Transaction History
Us Bancorp \De\
- $78.3 Billion
- Q2 2025
A detailed history of Us Bancorp \De\ transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 17,808 shares of CTKB stock, worth $68,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,808
Previous 10,680
66.74%
Holding current value
$68,026
Previous $42,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CTKB
# of Institutions
152Shares Held
72.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$65.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$29.7 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.11MShares$27.2 Million0.72% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$25.4 Million0.93% of portfolio
-
State Street Corp Boston, MA4.17MShares$15.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $514M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...